MEI Pharma (NASDAQ:MEIP – Get Rating) and Pharming Group (NASDAQ:PHAR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings. Profitability This table compares MEI Pharma and Pharming Group’s […]
MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) has been given a consensus rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the company. […]
StockNews.com cut shares of MEI Pharma (NASDAQ:MEIP – Get Rating) from a buy rating to a hold rating in a report issued on Wednesday morning. Several other analysts have also recently commented on the company. Jefferies Financial Group cut MEI Pharma from a hold rating to an underperform rating in a research report on Wednesday, […]
MEI Pharma (NASDAQ:MEIP – Get Rating) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. MEIP has been the topic of a number of other reports. Piper Sandler cut shares of MEI Pharma from an “overweight” rating to a “neutral” rating […]
MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 236,100 shares, a decline of 95.6% from the March 31st total of 5,340,000 shares. Approximately 3.9% of the shares of the company are sold […]